Mining stands at the core of Zion Holding’s strategy.
Our investments focus on gold and rare minerals, including coltan, a vital element for modern electronics, energy storage, and advanced technologies.
Gold – A Timeless Asset
Gold has remained a universal store of value and a hedge against global uncertainty. Our mining operations combine stability with significant growth potential.
Strategic Minerals
Beyond gold, we invest in minerals essential for global industries, from electronics to renewable energy.
Responsible Mining
We adhere to the highest international ESG standards:
Reducing environmental footprint.
Creating employment and training opportunities for local communities.
Driving sustainable economic and social development.
Real estate forms a strategic pillar of Zion Holding’s global portfolio.
We pursue opportunities wherever strong business potential exists, leveraging a global perspective and long-term value creation.
Types of Investments:
Luxury Properties – exclusive villas, seafront estates, and prime residences.
Income-Producing Assets – commercial buildings, office spaces, and tourism-related properties.
Development & Value-Add Projects – identifying and transforming properties with strong appreciation potential.Global Outlook
Our real estate activities span Europe, Africa, the Americas. Each investment is carefully evaluated, ensuring a balance between stability, growth, and opportunity.
Zion Holding invests in groundbreaking pharmaceutical ventures addressing some of the world’s most urgent medical needs. This reflects our dual mission of driving economic value while improving human health.
Key Focus Areas:
HIV / AIDS – developing advanced therapies to improve quality of life and reduce side effects.
Cancer – investing in research for targeted therapies and biological treatments.
Other Diseases – pioneering solutions for rare and underserved medical conditions.
Innovation & Excellence
Our pharmaceutical investments work in collaboration with world-class universities, research centers, and regulatory authorities (FDA, EMA).
Dual Value
Pharma represents both a force for global well-being and a sector of significant economic opportunity.